Načítá se...
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis
Background: Anemia is a common complication of chronic kidney disease (CKD). Treating renal anemia with erythropoiesis-stimulating agents (ESAs) or erythropoietin analogs is effective but has side effects. Therefore, we performed a meta-analysis to assess the efficacy and safety of roxadustat in tre...
Uloženo v:
| Vydáno v: | Aging (Albany NY) |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8312415/ https://ncbi.nlm.nih.gov/pubmed/34115611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.203143 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|